When the going gets hard, it’s common for some business VCs to head for the hills.

Today, it’s a narrative that’s emerging once again amid the COVID-19 crisis. International corporate venture offers fell from a total of 580 in April/May of 2019 to 486 in the exact same duration this year, according to International Business Venturing.

Nevertheless, institutional VC deals are also headed for a decline, with PitchBook anticipating a drop in transaction volume over the next numerous quarters, as well as a slump in evaluations.

Image Credits: International Business Venturing It stays to be seen how it will play out this time, but I believe corporate equity capital (CVC) will not only stick around, however also be an essential part of the development ecosystem moving forward.

I understand that Merck Global Health Innovation Fund (MGHIF) stays fully dedicated to “doing” endeavor. Now, more than ever, health development is vital. Second, we understand that much of today’s most successful business were moneyed in times of unpredictability. In truth, to put our money where our mouth is, we’ve just recently completed 2 spinouts, three follow-on financial investments, and two brand-new deals in 2020– all considering that COVID hit. We plan to increase that pace moving forward in 2020 and beyond.

It hasn’t been simple. It’s hard to do venture when you can’t venture out into the world, meet founders and do diligence the method we did in the past. It is possible, if you do some innovating of your own and set up an efficiently operating system to do CVC virtually.

Here’s how we have actually done it.

Discovering real advantages in virtual CVC

Article curated by RJ Shara from Source. RJ Shara is a Bay Area Radio Host (Radio Jockey) who talks about the startup ecosystem – entrepreneurs, investments, policies and more on her show The Silicon Dreams. The show streams on Radio Zindagi 1170AM on Mondays from 3.30 PM to 4 PM.